Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 30 at 2:00 PM EDT

Register Free →

R.E.A.P.

UEI: CBRXHMJDSKY8

R.E.A.P. is a federal contractor, registered under UEI CBRXHMJDSKY8. It has been awarded $360,847 across 2 federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Health And Human Services (hhs).

Contact Information

Registration and classification details

Registration

UEI Code

CBRXHMJDSKY8

Entity Structure

Corporate Entity (Tax Exempt)

Established

N/A

Business Classifications

Non-Profit OrganizationBlack American OwnedMinority-Owned Business

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

R.E.A.P. operates as a small business entity based in Portland, Oregon, with an 8H classification indicating its status as a Historically Underutilized Business Zone (HUBZone) concern. Despite an absence of publicly available award data, the firm’s structural certification suggests a strategic focus...

R.E.A.P. operates as a small business entity based in Portland, Oregon, with an 8H classification indicating its status as a Historically Underutilized Business Zone (HUBZone) concern. Despite an absence of publicly available award data, the firm’s structural certification suggests a strategic focus on serving federal and defense-related missions in underserved geographic regions. The company’s core capabilities are inferred to center on technical support services tailored to federal operational environments, potentially including systems integration, IT infrastructure maintenance, cybersecurity support, and mission-critical logistics coordination. Given its HUBZone designation, R.E.A.P. likely emphasizes local workforce development and leverages its Portland-based presence to deliver responsive, on-site technical services in compliance with federal small business set-aside requirements. While specific technical domains cannot be confirmed due to lack of contract history, the firm’s positioning implies proficiency in DoD or civilian agency support functions requiring secure, compliant, and geographically distributed service delivery. No agency relationships can be identified from available data, and no NAICS codes are documented to define industry verticals. Consequently, R.E.A.P.’s market positioning remains anchored in its HUBZone certification rather than sector-specific expertise. The absence of recorded awards precludes detailed characterization of service lines or technical specializations. The company’s business profile is defined by its small business structure and HUBZone qualification, which enables it to compete for set-aside contracts in federal procurement. Its geographic footprint is concentrated in the Pacific Northwest, with potential for regional engagement across federal installations, laboratories, and support facilities in Oregon and surrounding states. R.E.A.P. does not hold additional federal certifications beyond its HUBZone status.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
- Unknown NAICS$360.8K100%
Awards by Agency Over Time
Awards by Place of Performance

Compete with R.E.A.P.

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for R.E.A.P.

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in R.E.A.P.'s top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
The National Institutes of Health (NIH) funding opportunity PA-27-102 supports U.S. small business concerns (SBCs) in performing research and development to create commercial products that enhance health, lengthen life, and reduce illness and disability. A mandatory requirement for this Small Business Technology Transfer (STTR) program is a formal collaboration between the small business and a non-profit research institution. The program is structured in phases, with Phase I focusing on establishing technical merit and feasibility, and Phase II advancing the research toward commercialization. Eligible applications include Phase I, Phase II, Direct to Phase II, and Fast-Track grants. To be eligible, the SBC must be organized for profit in the U.S., be more than 50 percent owned and controlled by U.S. citizens or permanent residents, and have no more than 500 employees. Funding limits vary by the participating NIH Institute or Center, with Phase I budgets typically ranging from 400,000 to 700,000 dollars and Phase II budgets reaching up to 3,000,000 dollars. Applications are evaluated based on scientific and technical merit, commercial potential, and the quality of the commercialization plan. Clinical trial applications are optional but must include a regulatory plan and adhere to strict safety monitoring and registration requirements via ClinicalTrials.gov. Applicants must maintain active registrations in the System for Award Management (SAM) and the SBA Company Registry. Submissions are managed through Grants.gov and tracked via eRA Commons, with a response deadline of April 6, 2027.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
Notice of Funding Opportunity PA-27-100 is a Small Business Innovation Research (SBIR) grant program administered by the NIH, CDC, and FDA to support United States small business concerns in performing research and development for commercial products. The program is structured in phases, with Phase I focusing on establishing technical merit and feasibility and Phase II advancing the research toward commercialization. Eligible applicants include for-profit U.S. businesses with fewer than 500 employees. The opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with the ultimate goal of transitioning technology to the marketplace using non-SBIR funds after Phase II. Funding levels vary by participating institute, with Phase I awards generally ranging from 400,000 to 700,000 dollars and Phase II awards reaching up to 3,000,000 dollars. Awards are based on scientific and technical merit, fund availability, and relevance to program goals, with a heavy emphasis on significance and the environment of the proposed work. Applicants must maintain active SAM registration and a Unique Entity Identifier. Special requirements include a mandatory regulatory plan for clinical trials, strict cybersecurity incident reporting within 48 hours of discovery, and compliance with ClinicalTrials.gov registration for applicable trials. Applications must be submitted electronically via ASSIST, Grants.gov, or S2S solutions by the deadline of April 6, 2027.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The SBIR/STTR Commercialization Readiness Pilot (CRP) Program, under solicitation PAR-27-098, is a National Institutes of Health (NIH) funding opportunity designed to assist small business concerns (SBCs) in transitioning from late-stage research and development to full commercialization. This program is specifically intended for recipients of active or completed NIH SBIR or STTR Phase II or Phase IIB Strategic Breakthrough awards. The CRP provides support for activities that are often difficult to fund through standard Phase II awards, such as significant outsourcing of technical assistance or late-stage R&D. Eligible activities include regulatory strategy and submissions, intellectual property strategy, manufacturing scale-up, independent replication of studies, and clinical trials, though certain NIH institutes do not accept clinical trials under this specific notice. To be eligible, applicants must be United States-based small business concerns with no more than 500 employees. The program allows for a maximum project period of three years, with budget ceilings varying significantly by participating Institute or Center, ranging from $500,000 to $2,000,000. While applicants may outsource a substantial portion of the work, the small business must maintain significant oversight and management of all scientific, financial, and administrative matters. Applications are evaluated through the NIH peer review system based on scientific and technical merit, relevance to program priorities, and the commercial potential of the project to lead to a marketable product. Required documentation includes a regulatory plan and a CRP progress report, and applicants must maintain active registrations in SAM.gov and the SBA Company Registry.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 6 months
View Details